financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Hercules Capital Gets Rating Upgrade at Morningstar DBRS
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hercules Capital Gets Rating Upgrade at Morningstar DBRS
Mar 7, 2025 4:47 AM

07:25 AM EST, 03/07/2025 (MT Newswires) -- Morningstar DBRS on Thursday upgraded Hercules Capital's ( HTGC ) long-term issuer and senior debt ratings to BBB (high) from BBB.

The ratings agency revised the trend on all ratings to stable from positive.

The upgrade reflects the company's "sustained strong operating performance" in 2024 despite challenges in the venture capital ecosystem, Morningstar said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Piramal Realty, Jio-bp join hands for installing EV charging stations in Mumbai
Piramal Realty, Jio-bp join hands for installing EV charging stations in Mumbai
Mar 23, 2023
According to a joint statement released by the companies, customers and visitors to Piramal’s residential projects will be able to charge their electric vehicles seamlessly at Jio-bp pulse EV charging stations at sites with the Jio-bp pulse mobile app.
 35 Indian-origin CEOs run global giants with over $1 trillion revenue
35 Indian-origin CEOs run global giants with over $1 trillion revenue
Mar 23, 2023
Indian-origin CEOs now lead global businesses worth over $1 trillion in revenue, including companies in the IT sector, healthcare and industrials. The combined trailing 12 months revenues of 35 companies managed by Indian CEOs stood at $1.08 trillion at the end of December 2022.
 Lupin gets tentative US FDA approval for Obeticholic Acid Tablets
Lupin gets tentative US FDA approval for Obeticholic Acid Tablets
Mar 23, 2023
"Company has received tentative U.S. FDA approval for its Abbreviated new Drug Application, Obeticholic Acid Tablets, 5 mg and 10 mg, to market a generic equivalent of Ocaliva Tablets, 5 mg and 10 mg, of Intercept Pharmaceuticals, Inc," the company said in a regulatory filing.
 Hikal promoters file suit against Baba Kalyani and Kalyani Group
Hikal promoters file suit against Baba Kalyani and Kalyani Group
Mar 23, 2023
The promoters of pharma firm Hikal, Jaidev Hiremath and Sugandha Hiremath, have filed a case against Baba Kalyani and Kalyani Group companies, also known as BNK Group, seeking “specific performance of obligations cast on BNK after a family arrangement.”
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2025 - www.financetom.com All Rights Reserved